Editas Medicine (EDIT) Revenue (2015 - 2026)
Editas Medicine (EDIT) revenue from Mar 31, 2015 to Mar 31, 2026. The TTM Editas Medicine (EDIT) revenue is $39M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
Quarterly Revenue
Editas Medicine (EDIT) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +7.95% |
| 3 Years TTM | +19.29% |
| 5 Years TTM | -15.82% |
| 10 Years TTM | +113.14% |
| All Time TTM | +113.16% |
Annual Revenue change of Editas Medicine (EDIT)
| Year | Revenue | Change |
|---|---|---|
| 2026 | $2.83M | -93.02% |
| 2025 | $41M | +25.41% |
| 2024 | $32M | -58.64% |
| 2023 | $78M | +296.35% |
| 2022 | $20M | -22.83% |
| 2021 | $26M | -71.85% |
| 2020 | $91M | +341.94% |
| 2019 | $21M | -35.72% |
| 2018 | $32M | +132.63% |
| 2017 | $14M | +126.94% |
| 2016 | $6.05M | -4421.43% |
| 2015 | -$140K | +366.67% |
| 2014 | -$30K | N/A |
Comparison Editas Medicine (EDIT) five years revenue CAGR with competitors
Editas Medicine (EDIT) five years revenue CAGR is -15.82%.